Skip to content
akaturk Academic measurement
Sign in Register

Academician

TOLGA ACUN

DOÇENT

ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ FEN FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ

A quick look at recorded outputs — details below.

  • Articles 14
  • Projects 0
  • Books 0
  • Proceedings 21
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 5 Q2 2 Q3 2 Q4 3
WoS (JCR) Q1 2 Q2 3 Q3 3 Q4 4
TR Index 2 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

14 publications total

Scopus (SJR)
Q1 5 Q2 2 Q3 2 Q4 3
WoS (JCR)
Q1 2 Q2 3 Q3 3 Q4 4
TR Index
2 articles

Article list

  1. 2023 DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival. Molecular biology reports DOI 10.1007/s11033-023-08654-4 YÖKSİS SJR Q2 JCR Q3
  2. 2023 Identification of ALX3 Gene Promoter Hypermethylation as a Potential Biomarker for Lung Cancer. Anticancer research DOI 10.21873/anticanres.16474 YÖKSİS SJR Q2 JCR Q4
  3. 2022 High DNAJA4 expression correlates with poor survival outcomes in breast cancer Revista Romana de Medicina de Laborator DOI 10.2478/rrlm-2022-0035 YÖKSİS SJR Q4 JCR Q4
  4. 2021 High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer BIOMARKERS IN MEDICINE DOI 10.2217/bmm-2020-0728 YÖKSİS SJR Q3 JCR Q4
  5. 2021 DNAJC25 as a tumor suppressor candidate gene in breast cancer Hacettepe Journal of Biology and Chemistry DOI 10.15671/hjbc.725263 YÖKSİS TR Index
  6. 2020 Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer Breast Cancer DOI 10.1007/s12282-019-01042-6 YÖKSİS SJR Q1 JCR Q1
  7. 2020 DNAJB11 (ERDJ3) Expression is a Novel Risk Factor for Breast Cancer Survival Journal of international translational medicine DOI 10.11910/2227-6394.2020.08.01.03 YÖKSİS SJR Q4
  8. 2017 HLJ1(DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer OMICS: A Journal of Integrative Biology DOI 10.1089/omi.2017.0016 YÖKSİS SJR Q1 JCR Q2
  9. 2016 Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma TURKISH JOURNAL OF MEDICAL SCIENCES DOI 10.3906/sag-1501-173 YÖKSİS TR Index SJR Q3 JCR Q3
  10. 2015 PTPRD is Homozygously Deleted and Epigenetically Downregulated in Human Hepatocellular Carcinomas OMICS: A Journal of Integrative Biology DOI 10.1089/omi.2015.0010 YÖKSİS SJR Q1 JCR Q2
  11. 2012 Muscle Hemangiomatosis Presenting as a Severe Feature in a Patient with the Pten Mutation: Expanding the Phenotype of Vascular Malformations in Bannayan-Riley-ruvalcaba Syndrome Balkan Journal of Medical Genetics DOI 10.2478/v10034-012-0007-x YÖKSİS SJR Q4 JCR Q4
  12. 2011 SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation BMC Cancer DOI 10.1186/1471-2407-11-223 YÖKSİS SJR Q1 JCR Q2
  13. 2010 Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis DOI 10.1016/j.mrfmmm.2009.11.008 YÖKSİS JCR Q1
  14. 2006 Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-β-1,3-glucanase activity Enzyme and Microbial Technology DOI 10.1016/j.enzmictec.2005.11.024 YÖKSİS SJR Q1 JCR Q3

Back to academicians